Citations

Institution: Mayo Clinic Clear

Showing 10 of 108104 citations.

Living Faith in Medicine
Spampinato, Christine, O’Donnell, Erin L.

The Linacre Quarterly | February 7, 2013 | Volume: 80 | Issue: 1 | Pages: 3-7

10.1179/0024363912z.0000000004 | PMID 24844574 Get It

Personhood and Embryo Adoption
Nelson, Thomas K.

The Linacre Quarterly | February 7, 2013 | Volume: 79 | Issue: 3 | Pages: 261-274

10.1179/002436312804872767 | PMID 30082974 Get It

The morality of embryo adoption, or heterologous embryo transfer for rescue, remains controversial despite the issuance of Dignitas personae (2008). When evaluating such bioethical controversies, it is crucial to take account of the personal order. Personalism provides a fresh and heretofore underdeveloped perspective toward resolving this polarized issue in bioethics. I will argue that it is not discriminatory to oppose embryo adoption on the basis of the heterology between rescuer and embryo because the lack of genetic relatedness reflects a more profound lack of personal relatedness. The persons involved in embryo adoption are not meant for the bodily relationship of pregnancy because of the incommunicability of relationships that involve the total gift of the human body. From the perspective of biology, pregnancy is natural life support for the embryo. From the perspective of personhood, pregnancy is fundamentally a relationship of embodied persons, one that is irreplaceable and radically exclusive. The clinical implications of this analysis will be discussed.
Carfilzomib
Kortuem, K. Martin, Stewart, A. Keith

Blood | February 7, 2013 | Volume: 121 | Issue: 6 | Pages: 893-897

10.1182/blood-2012-10-459883 | PMID 23393020 Get It

Abstract This spotlight review focuses on the second-generation proteasome inhibitor carfilzomib, which was recently approved by the US Food and Drug Administration for treatment of relapsed and refractory multiple myeloma patients who have received at least 2 prior therapies, including bortezomib and an immunomodulatory agent, and have demonstrated disease progression on or within 60 days of the completion of the last therapy. This review focuses on clinical trial data leading to drug approval and provides advice for treating physicians who are now accessing this drug for patients.
Fat Depots, Free Fatty Acids, and Dyslipidemia
Ebbert, Jon O. , Jensen, Michael D.

Nutrients | February 7, 2013 | Volume: 5 | Issue: 2 | Pages: 498-508

10.3390/nu5020498 | PMID 23434905 Get It

Body fat deposition and excess free fatty acid (FFA) metabolism contribute to dyslipidemia and the adverse health consequences of obesity. Individuals with upper body obesity have impaired functioning of adipocytes, the primary fatty acid storage site. Excess visceral fat is strongly associated with impaired suppression of FFA release in response to insulin, as well as with hypertriglyceridemia and low concentrations of high density lipoprotein (HDL) cholesterol. High FFA concentrations can induce insulin resistance in muscle and liver. Furthermore, failure of hyperinsulinemia to normally suppress FFA is associated with impaired carbohydrate oxidation and muscle glucose storage, reduced hepatic insulin clearance and elevated triglycerides. Understanding the impact of body fat distribution on FFA metabolism and dyslipidemia is critical for determining the link between overweight and obesity and cardiovascular disease risk. In the current review, we will explore the relationship between adipose tissue, body fat depots, and FFA metabolism.
Achromobacter piechaudii bloodstream infection in an immunocompetent host
Krause, Megan L., Patel, Robin , Wittich, Christopher M. , Sohail, M. Rizwan , Patel, Robin

American Journal of Case Reports | February 7, 2013 | Volume: 13 | Issue: No issue available | Pages: 265-267

10.12659/ajcr.883527 | PMID 23569545 Get It

Alzheimer disease biomarkers and insights into mild cognitive impairment
Knopman, David S.

Neurology | February 7, 2013 | Volume: 80 | Issue: 11 | Pages: 978-980

10.1212/wnl.0b013e31828728ac | PMID 23390186 Get It

Cultural Competence Training for Clinical Staff
Delgado, Deborah Ann, Ness, Sheryl M. , Ferguson, Kathy E. , Engstrom, P, Gannon, Theresa M., Gillett, Craig, Delgado, Deborah A.

Journal of Transcultural Nursing | February 6, 2013 | Volume: 24 | Issue: 2 | Pages: 204-213

10.1177/1043659612472059 | PMID 23389745 Get It

In an environment of changing demographics and health care disparities, it is essential that nurses continue to develop competence in providing care across cultures. This article presents the findings of a pilot project to measure and compare self-reported cultural competence scores before and after participation in one of the core classes of a cultural competence curriculum. Cultural competence of the staff of a patient care unit ( N = 98) was assessed prior to the class, at 3 months, and at 6 months posteducation using the Inventory for Assessing the Process of Cultural Competence Among Healthcare Professionals–Revised. The results demonstrated that following an educational intervention the participants self-reported a statistically significant increase ( p = .03) in cultural competence within the category range of cultural awareness. Providing cultural competence education may better equip nurses to care for patients from diverse cultures.
The rate of successful four-corner arthrodesis with a locking, dorsal circular polyether-ether-ketone (PEEK-Optima) plate
Rhee, Peter C. , Shin, Alexander Y. , Shin, Alexander Y

Journal of Hand Surgery (European Volume) | February 6, 2013 | Volume: 38 | Issue: 7 | Pages: 767-773

10.1177/1753193413475962 | PMID 23390151 Get It

The purpose of this study is to evaluate the rate of union after four-corner arthrodesis with a locking, dorsal circular plate comprised of polyether-ether-ketone. A retrospective review was conducted of all patients who underwent four-corner arthrodesis with a locking, dorsal circular plate at our institution from January 2005 to May 2009. The primary outcome measure was radiographic and clinical union. During the study period, 26 consecutive wrists underwent four-corner arthrodesis with a locking, dorsal circular plate. Twenty-three wrists were included. The mean clinical follow-up was 16 months (range 3–37). Union was achieved in 22 of 23 wrists at a mean time of 3 months (range 1–12). There was one partial union that underwent successful revision arthrodesis. In summary, four-corner fusion with a polyether-ether-ketone locking, dorsal circular plate results in high union rates. The use of a radiolucent plate allows for more accurate assessment of union with the biomechanical advantages of a fixed angle construct.
Letter from Cancer Survivorship and Sexual Health Symposium Co-Chairs
Broderick, Gregory A. , Incrocci, Luca

The Journal of Sexual Medicine | February 6, 2013 | Volume: 10 | Issue: Supplement_1 | Pages: 3-4

10.1111/jsm.12078 | PMID 23387906 Get It

Androgen Deprivation Therapy Impact on Quality of Life and Cardiovascular Health, Monitoring Therapeutic Replacement
Trost, Landon , Şerefoğlu, Ege Can , Gökçe, Ahmet , Linder, Brian J. , Sartor, Alton Oliver, Hellstrom, Wayne J.G. , Linder, Brian J

The Journal of Sexual Medicine | February 6, 2013 | Volume: 10 | Issue: Supplement_1 | Pages: 84-101

10.1111/jsm.12036 | PMID 23387914 Get It

ABSTRACTIntroductionAndrogen deprivation therapy (ADT) is commonly utilized in the management of both localized and advanced adenocarcinoma of the prostate. The use of ADT is associated with several adverse events, physical changes, and development of medical comorbidities/mortality.AimThe current article reviews known adverse events associated with ADT as well as treatment options, where available. Current recommendations and guidelines are cited for ongoing monitoring of patients receiving ADT.MethodsA PubMed search of topics relating to ADT and adverse outcomes was performed, with select articles highlighted and reviewed based on level of evidence and overall contribution.Main Outcome MeasuresReported outcomes of studies detailing adverse effects of ADT were reviewed and discussed. Where available, randomized trials and meta-analyses were reported.ResultsADT may result in several adverse events including decreased libido, erectile dysfunction, vasomotor symptoms, cognitive, psychological and quality of life impairments, weight gain, sarcopenia, increased adiposity, gynecomastia, reduced penile/testicular size, hair changes, periodontal disease, osteoporosis, increased fracture risk, diabetes and insulin resistance, hyperlipidemia, and anemia. The definitive impact of ADT on lipid profiles, cardiovascular morbidity/mortality, and all-cause mortality is currently unknown with available data. Treatment options to reduce ADT-related adverse events include changing to an intermittent treatment schedule, biophysical therapy, counseling, and pharmacotherapy.ConclusionsPatients treated with ADT are at increased risk of several adverse events and should be routinely monitored for the development of potentially significant morbidity/mortality. Where appropriate, physicians should reduce known risk factors and counsel patients as to known risks and benefits of therapy.